Time for change, WHO

The World Health Organization has long term relationships with the pharmaceutical industry1 2 and even conceives of industry as a “partner.”3 Now Cohen and Carter show that WHO chose not to disclose financial conflicts of interest among industry sponsored experts guiding its influenza policy.4 …

[1]  Margaret Chan,et al.  WHO Director-General replies to the BMJ , 2010, BMJ : British Medical Journal.

[2]  D. Cohen,et al.  WHO and the pandemic flu “conspiracies” , 2010, BMJ : British Medical Journal.

[3]  D. Cohen.  Complications: tracking down the data on oseltamivir , 2009, BMJ : British Medical Journal.

[4]  Peter Doshi,et al.  Neuraminidase inhibitors—the story behind the Cochrane review , 2009, BMJ : British Medical Journal.

[5]  Tom Jefferson,et al.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.